Prostate Cancer Treatment | Colorado Cyberknife VSI Prostate Cancer Surgery

http://www.coloradocyberknife.com/cyberknife-treatment-for/prostate-cancer-tu...
The first published five-year outcomes on low risk prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System. The multi-center study, published in the January 10, 2011 issue of Radiation Oncology, found that 93 percent of patients had no recurrence of their cancer at a median follow-up of five years, a rate that compares favorably to results obtained with other treatment modalities, including surgery and conventional radiation therapy.
"As a non-invasive treatment option completed in just five visits, stereotactic radiotherapy with the CyberKnife System offers patients the benefits of more rapid recovery, reduced travel costs and less time off work, allowing them to return to their normal, daily routines almost immediately as compared with the standard nine-week course of radiotherapy," said Christopher King, M.D., an author on the study who is now an Associate Professor of Radiation Oncology and Urology at the UCLA School of Medicine. "In addition, because CyberKnife radiosurgery costs less than conventional radiation and avoids the anesthesia and hospital stay associated with surgery, our national health care system benefits from reduced health care costs."

Category:

Education

Tags:

• prostate cancer treatment
• prostate cancer surgery